Insmed Inc (INSM)vsYD Bio Ltd (YDES)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
YDES
YD Bio Ltd
$7.73
+19.11%
HEALTHCARE · Cap: $457.68M
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 118723% more annual revenue ($606.42M vs $510,360). INSM leads profitability with a -2.1% profit margin vs -2.8%. INSM earns a higher WallStSmart Score of 39/100 (F).
INSM
Hold39
out of 100
Grade: F
YDES
Avoid22
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Revenue surging 95.6% year-over-year
Reasonable price relative to book value
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -42.7% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : YDES
The strongest argument for YDES centers on Revenue Growth, Price/Book. Revenue growth of 95.6% demonstrates continued momentum.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : YDES
The primary concerns for YDES are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
INSM profiles as a turnaround stock while YDES is a hypergrowth play — different risk/reward profiles.
INSM carries more volatility with a beta of 1.17 — expect wider price swings.
YDES is growing revenue faster at 95.6% — sustainability is the question.
YDES generates stronger free cash flow (-298,190), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 22/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
YD Bio Ltd
HEALTHCARE · BIOTECHNOLOGY · USA
Breeze Holdings Acquisition Corp. The company is headquartered in Taipei, Taiwan.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?